TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database

被引：0
|
作者：
Victor D. Li
Karen H. Li
John T. Li
机构：
[1] The Wheatley School,Department of Science
来源：
Journal of Cancer Research and Clinical Oncology | 2019年 / 145卷
关键词：
TP53; p53; Cancer; Prognostic marker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：625 / 636
页数：11
相关论文
共 50 条
  • [1] TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database
    Li, Victor D.
    Li, Karen H.
    Li, John T.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (03) : 625 - 636
  • [2] Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set An International Agency for Research on Cancer TP53 Database Analysis
    Kratz, Christian P.
    Freycon, Claire
    Maxwell, Kara N.
    Nichols, Kim E.
    Schiffman, Joshua D.
    Evans, D. Gareth
    Achatz, Maria, I
    Savage, Sharon A.
    Weitzel, Jeffrey N.
    Garber, Judy E.
    Hainaut, Pierre
    Malkin, David
    JAMA ONCOLOGY, 2021, 7 (12) : 1800 - 1805
  • [3] The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute
    de Andrade, Kelvin Cesar
    Lee, Elaine E.
    Tookmanian, Elise M.
    Kesserwan, Chimene A.
    Manfredi, James J.
    Hatton, Jessica N.
    Loukissas, Jennifer K.
    Zavadil, Jiri
    Zhou, Lei
    Olivier, Magali
    Frone, Megan N.
    Shahzada, Owais
    Longabaugh, William J. R.
    Kratz, Christian P.
    Malkin, David
    Hainaut, Pierre
    Savage, Sharon A.
    CELL DEATH AND DIFFERENTIATION, 2022, 29 (05): : 1071 - 1073
  • [4] The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute
    Kelvin César de Andrade
    Elaine E. Lee
    Elise M. Tookmanian
    Chimene A. Kesserwan
    James J. Manfredi
    Jessica N. Hatton
    Jennifer K. Loukissas
    Jiri Zavadil
    Lei Zhou
    Magali Olivier
    Megan N. Frone
    Owais Shahzada
    William J. R. Longabaugh
    Christian P. Kratz
    David Malkin
    Pierre Hainaut
    Sharon A. Savage
    Cell Death & Differentiation, 2022, 29 : 1071 - 1073
  • [5] TP53 and mutations in human cancer
    Szymanska, K
    Hainaut, P
    ACTA BIOCHIMICA POLONICA, 2003, 50 (01) : 231 - 238
  • [6] TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
    Bouaoun, Liacine
    Sonkin, Dmitriy
    Ardin, Maude
    Hollstein, Monica
    Byrnes, Graham
    Zavadil, Jiri
    Olivier, Magali
    HUMAN MUTATION, 2016, 37 (09) : 865 - 876
  • [7] Coordination of TP53 Abnormalities in Breast Cancer: Data from Analysis of TP53 Polymorphisms, Loss of Heterozygosity, Methylation, and Mutations
    Denisov, Evgeny V.
    Sukhanovskaya, Tatiana V.
    Dultseva, Tatiana S.
    Malinovskaya, Elena A.
    Litviakov, Nicolay V.
    Slonimskaya, Elena M.
    Choinzonov, Evgeny L.
    Cherdyntseva, Nadezhda V.
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2011, 15 (12) : 901 - 907
  • [8] Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
    Kyndi, M
    Alsner, J
    Hansen, LL
    Sorensen, FB
    Overgaard, J
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S54 - S54
  • [9] Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
    A Langerød
    TI Andersen
    I Bukholm
    A-L Børresen Dale
    Breast Cancer Research, 2 (Suppl 1)
  • [10] TP53 mutations are not prognostic independent indicators in bladder cancer
    Agnese, V.
    Corsale, S.
    Augello, C.
    Bruno, L.
    Calo, V.
    Cammareri, P.
    Cascio, S.
    Gargano, G.
    Gregorio, V.
    Gullo, A.
    La Rocca, G.
    Sisto, P. S.
    Valerio, M. R.
    Di Fede, G.
    Martorana, A.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2005, 16 : 152 - 152
12345